Equity Arbitrage Explained for Practice Owners
If you’ve been approached by a DSO, you’ve probably heard the term “equity arbitrage” thrown around — usually attached to a promise that rolling over part of your proceeds instead of taking all cash could be worth more down the road. It’s not a sales gimmick. It’s a real mechanic behind how consolidation creates value, and understanding it is the difference between evaluating an offer and just trusting one.
The Basic Idea
Equity arbitrage, in simple terms, is the gap between what your practice is worth on its own and what it’s worth once it’s folded into a larger platform.
A single, well-run practice typically sells on its own for somewhere in the range of 5–8x EBITDA. But once that same practice is combined with dozens or hundreds of others under one DSO platform, the platform — not the individual practice — often trades at a meaningfully higher multiple, sometimes into the low-to-mid teens, when the DSO itself is later sold or recapitalized to a larger investor.
That gap between the multiple a single practice sells at and the multiple the combined platform later sells at is the arbitrage. And if you’ve rolled a portion of your proceeds into equity in that platform, you’re no longer just a seller who got paid once — you own a slice of that gap.
Why the Platform Is Worth More Than the Sum of Its Parts
The uplift isn’t arbitrary. A handful of concrete factors typically drive it:
- Diversified risk. One practice depends heavily on one owner, one location, one local market. A platform of a hundred practices doesn’t carry that same single-point-of-failure risk, which makes it more attractive — and more valuable per dollar of EBITDA — to a larger investor.
- Economies of scale. Shared back-office functions, group purchasing power on supplies and equipment, and centralized marketing and scheduling infrastructure all improve margins across the platform in ways a solo practice can’t replicate.
- Growth trajectory. A platform that’s actively acquiring and integrating new practices tells a growth story that a single, mature practice generally can’t — and growth stories command premium multiples.
What This Means for Your Rollover Equity
When a DSO offers a deal that’s part cash and part rollover equity, that equity is typically priced against the platform’s future exit value, not just today’s practice-level multiple. In a favorable structure, that means your rolled equity has real upside built in from day one — the well-known “second bite of the apple” that many practice owners end up valuing as highly as the initial cash payment, sometimes more.
But the arithmetic only works in your favor if a few things hold true:
- The multiple gap is real and durable. Platform multiples move with market conditions — interest rates, PE fundraising activity, and buyer appetite all affect what a platform eventually sells for. The spread that looks attractive today isn’t guaranteed to hold for the 5–7 years it typically takes to reach a liquidity event.
- The valuation basis is consistent. Some structures apply a lower multiple to price your rollover equity than the multiple used to value the overall deal. If that happens, you’re effectively buying your equity stake at a markup relative to what the numbers on the term sheet suggest — worth checking closely before you sign.
- The platform itself is healthy. A heavily leveraged DSO carrying significant debt relative to its EBITDA has less room for error, and less certainty of reaching a strong exit. Equity in a fragile platform is a different bet than equity in a well-capitalized one, even if the headline terms look similar.
The Practical Takeaway
Equity arbitrage is the reason rollover equity can meaningfully outperform straight cash over time — but it’s a bet on the platform’s future, not a guaranteed multiplier. Before treating a rollover offer as “extra” value on top of your cash proceeds, it’s worth understanding the platform’s current multiple, its debt load, its growth plans, and — critically — whether your equity is being priced on the same basis as the rest of the deal.
If you want a clearer read on how a specific offer’s equity component stacks up, that’s exactly the kind of analysis we walk practice owners through before they commit to a structure.